We define research as systematic investigation designed to contribute to generalizable knowledge.
How Does the Kidney Cancer Association (KCA) Promote Research?
We encourage both private and public sector institutions to do more research on kidney cancer. We help researchers in academic medical centers, government, and industry with money and information. We are a catalyst for new ideas. For example, we provide financial grants for basic research into the biology of kidney cancer. KCA members work to raise funds. These competitive awards are made from a pool of funds named in honor of the Association’s late founder, Eugene P. Schonfeld, Ph.D.
Young Investigator Award
KCA funds early-career cancer researchers through its Young Investigator Award (YIA) that provides funding to promising investigators to encourage and promote quality research in urology and clinical oncology. The purpose of this grant is to fund physicians and scientists during the transition from a fellowship program to a faculty appointment. Awards given are based on individual merit and availability of funds.
We have been represented in the membership of the National Cancer Institute’s Renal Cancer Task Force, Biomarkers Consortium, Kidney Cancer SPORE, Cancer Leadership Council, Friends of Cancer Research, National Council of Research Advocates, and many more collaborations, including our participation in The Cancer Genome Atlas.
No charitable organization of our size has sponsored a greater number of kidney cancer research projects over the past 25 years. View examples of some of the many Young Investigator Awards and research grants made through generous contributions to the Eugene P. Schonfeld Fund.
The Kidney Cancer Journal
The Kidney Cancer Journal serves as the most comprehensive, peer-reviewed resource of information for physicians on the diagnosis and treatment of renal cell carcinoma and all of its tumor types.
Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the kidney.
The National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.